Loss of heterozygosity at tumor suppressor genes detectable on fractionated circulating cell-free tumor DNA as indicator of breast cancer progression.

  • Heidi Schwarzenbach
  • Corinna Eichelser
  • Jolanthe Kropidlowski
  • Wolfgang Janni
  • Brigitte Rack
  • Klaus Pantel

Related Research units

Abstract

LOH on circulating DNA may provide tumor-specific information on breast cancer. As identification of LOH on cell-free DNA is impeded by the prevalence of wild type DNA in blood of cancer patients, we fractionated plasma DNA, and determined the diagnostic and prognostic value of both fractions.

Bibliographical data

Original languageEnglish
Article number20
ISSN1078-0432
Publication statusPublished - 2012
pubmed 23014523